Chief Accounting Officer Mary Scherer of Cardinal Health Inc (CAH, Financial) sold 3,504 shares of the company on November 14, 2024, according to a recent SEC Filing. Following this transaction, the insider now owns 8,752 shares of the company.
Cardinal Health Inc (CAH, Financial) is a global, integrated healthcare services and products company, providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices worldwide. The company provides clinically-proven medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency from hospital to home.
Over the past year, Mary Scherer has sold a total of 3,504 shares and has not purchased any shares. The insider transaction history for Cardinal Health Inc shows that there have been no insider buys and 9 insider sells over the past year.
Shares of Cardinal Health Inc were trading at $123.55 on the day of the transaction. The company has a market cap of approximately $29.35 billion. The price-earnings ratio of the company stands at 23.60, which is above the industry median of 19.97 and also higher than the company’s historical median.
According to the GF Value, the intrinsic value of Cardinal Health Inc is estimated at $103.01 per share, making the stock modestly overvalued with a price-to-GF-Value ratio of 1.2.
The GF Value is calculated based on historical trading multiples such as the price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, adjusted for the company’s past performance and expected future business results provided by Morningstar analysts.
This sale by the insider may be of interest to current and potential investors, providing insight into the insider's perspective on the stock's current valuation and future prospects.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
